Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations

Details for Australian Patent Application No. 2006225117 (hide)

Owner Elan Pharma International Limited

Inventors Bosch, H.; Wertz, Christian; Jenkins, Scott; Liversidge, Gary

Agent Davies Collison Cave

Pub. Number AU-A-2006225117

PCT Pub. Number WO2006/099591

Priority 60/662,339 16.03.05 US

Filing date 16 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/404 (2006.01)

A61K 31/573 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/099591 Priority application(s): WO2006/099591

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006225120-System and method for treating connective tissue

2006225116-Modified Clostridial toxins with altered targeting capabilities for Clostridial toxin target cells